{
  "url": "https://openlegislation.uk/eu-regulation-1996-2034/annex",
  "json_url": "https://openlegislation.uk/eu-regulation-1996-2034/annex.json",
  "legislation": "eur/1996/2034",
  "legislation_title": "Commission Regulation (EC) No 2034/96 of 24 October 1996 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin",
  "legislation_url": "https://openlegislation.uk/eu-regulation-1996-2034",
  "path": "annex",
  "kind": "annex",
  "number": null,
  "heading": null,
  "text": "Regulation (EEC) No 2377/90 is amended as follows:\nA.. Annex I is modified as follows:\n1.. Anti-infectious agents\n1.2. Antibiotics\n1.2.1. Penicillins\nPharmacollogically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘1.2.1.7.\nPenethamate\nBenzylpenicillin\nBovine\n50 μg/kg\nKidney, liver, muscle, fat\n4 μg/kg\nMilk’\nB.. Annex II is modified as follows:\n1.. Inorganic chemicals\nPharmacollogically active substance(s)\nAnimal species\nOther provisions\n‘1.8.\nBoric acid and borates\nAll food producing species’\n2.. Organic compounds\nPharmacollogically active substance(s)\nAnimal species\nOther provisions\n‘2.34.\nPolysulphated glycosaminoglycan\nHorses\n2.35.\nRifaximin\nBovine\nFor intramammary use — except if the udder may be used as food for human consumption — and intrauterine use only\n2.36.\nTau fluvalinate\nHoney bees’\n5.. Substances used as food additives in foodstuffs for human consumption\nOJ No L 61, 18. 3. 1995, p. 1.’\nPharmacollogically active substance(s)\nAnimal species\nOther provisions\n‘5.1.\nSubstances with an E number\nAll food producing species\nOnly substances approved as additives in foodstuffs for human consumption, with the exception of preservatives listed in part C of Annex III to Council Directive 95/2/CE\nC.. Annex III is modified as follows:\n1.. Anti-infectious agents\n1.2. Antibiotics\n1.2.7. Naphtalene-ringed ansamycin\nPharmacollogically active substance(s)\nMarker residue\nAnimal species\nMRLs\nTarget tissues\nOther provisions\n‘1.2.7.1.\nRifaximin\nRifaximin\nBovine\n60 μg/kg\nMilk\nProvisional MRL expires on 1. 6. 1998’",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "OJ No L 61, 18. 3. 1995, p. 1.’"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/1996/2034/annex",
    "retrieved_at": "2026-11-01T14:59:02.977879+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}